News brief
Finnair to offer long-haul routes from Sweden to Bangkok and Phuket
F
inland’s flag carrier Finnair will this winter be offering direct flights from Arlanda, Stockholm to Bangkok, and Phuket in Thailand. According to Breaking travel News, star ting from 22 October,
Finnair will be flying from Arlanda to Bangkok five times a week on Mondays, Tuesdays, Thursdays, Fridays, and Sundays on its Airbus A350. Come 28 November, Finnair will be increasing the weekly frequencies to
seven days a week operating from Monday through Sunday until 22 April next year. In addition, Finnair will also be flying from Arlanda into Phuket on Sundays starting on 24 October. Ole Orvér, chief commercial officer, Finnair says that Thailand is amongst the top winter destinations for Swedes and the air carrier is excited to meet the travel needs of their Swedish customers with the non-stop service from Sweden to Thailand. “The new flights will strengthen our offering in the Swedish market,” he says. Finnair also flies to Bangkok and Phuket from its home base Helsinki Airport.
Novo Nordisk to raise the amount of clinical trial investment in Thailand
J
ohn Dawber, Vice President and General Manager of Novo Nordisk Pharma (Thailand) Limited, talked in a recent article in Bangkok Post, amongst other things, about the company’s plan looking towards the next ten years and its aim to raise the amounts of clinical trial investment in Thailand. Despite the pandemic and the challenges it has brought along, Novo Nordisk has a strong presence in Thailand and the company’s growth rate was more than 20 percent last year with a revenue of THB 2.2 billion. According to John Dawber, Novo Nordisk’s success 32 ScandAsia • Septembert 2021
can be described through four aspects: ‘Partnership’ with the government and authorities, ‘Products’ that are good, ‘People’ and experts who drive the company forward, and ‘Passion’ to improve the lives of Thai patients. Looking towards the next 10 years, Novo Nordisk expects to have a strong partnership with the Thai FDA as well as a high level of expertise of Thai doctors. Between 2016-2020 Novo Nordisk invested THB 189 million in clinical trials in Thailand and the company aims at raising that from 2021 to 2025 to up to THB 300.000 million.
John Dawber, Vice President and General Manager of Novo Nordisk Pharma (Thailand) Limited
